This activity is intended for primary care physicians, hospitalists, infectious disease specialists, nurses, nurse practitioners, physician assistants, pharmacists and other members of the healthcare team who care for patients at risk for Clostridioides difficile (C. Difficile) infection.
The goal of this activity is for learners to be better be able to distinguish elements of a quality improvement project designed to reduce the rate of hospital-onset C. Difficile infection.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-201-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 7/1/2023. Pas should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 7/1/2022
Valid for credit through: 7/1/2023, 11:59 PM EST
processing....
Clostridium difficile remains a significant source of morbidity and mortality among hospitalized adults, as well as a major financial burden on the healthcare system. The authors of the current study provide a review of the microbiology and effect of C difficile.
C difficile is a Gram-positive bacterium that is transmitted via the fecal-oral route. The use of antibiotics raises the risk for C difficile infection (CDI), as do older age, hospitalization, immunosuppression, gastrointestinal surgery, and the use of proton pump inhibitors.
There are approximately 500,000 cases of CDI in the US annually, and hospital-acquired CDIs are a major quality metric for health systems. Members of the healthcare team, including physicians, nurses nurse practitioners, physician assistants, pharmacists, and infectious disease specialists, each play an important role in the prevention and management of CDI. The current study describes the multifaceted infection control program against CDI at a single US community hospital, as well as the efficacy of that intervention.
Teamwork by a wide range of professional staff, coupled with support from leadership, enabled a single academic community hospital to cut its rate of hospital-onset CDIs (HO-CDIs) by almost two thirds in 1 year and by more than three quarters in 3 years, a study published in the American Journal of Infection Control reports.[1]
"The interventions and outcomes of the project improved patient care by ensuring early testing, diagnosis, treatment if warranted, and proper isolation, which helped reduce C difficile transmission to staff and other patients," lead study author Cherith Walter, MSN, RN, a clinical nurse specialist at Emory Saint Joseph's Hospital in Atlanta, Georgia, told Medscape Medical News. "Had we not worked together as a team, we would not have had the ability to carry out such a robust project," she added in an email.
Each HO-CDI case costs a healthcare system an estimated $12,313, and high rates of HO-CDIs incur fines from the Hospital-Acquired Condition Reduction Program of the Centers for Medicare & Medicaid Services (CMS), the authors write.
A Diverse Staff Team Collaborated
Emory Saint Joseph's, a 410-bed hospital in Atlanta, had a history of being above the national CMS benchmark for HO-CDIs. To reduce these infections, comply with CMS requirements, and avoid fines, Walter and colleagues launched a quality improvement project between 2015 and 2020.
With the approval of the chief nursing officer, chief quality officer, and hospital board, researchers mobilized a diverse team of professionals: a clinical nurse specialist, a physician champion, unit nurse champions, a hospital epidemiologist, an infection preventionist, a clinical microbiologist, an antimicrobial stewardship pharmacist, and an environmental services representative.
The team investigated what caused their hospital's HO-CDIs from 2014 through 2016 and developed appropriate, evidence-based infection prevention interventions. The integrated approach involved:
After 1 year, HO-CDI incidence dropped 63% from baseline, from above 12 cases per 10,000 patient-days to 4.72 per 10,000 patient-days. And after 3 years, infections dropped 77% to 2.80 per 10,000 patient-days.
The hospital's HO-CDI standardized infection ratio, or the total number of infections divided by the National Healthcare Safety Network's risk-adjusted predicted number of infections, dropped below the national benchmark, going from 1.11 in 2015 to 0.43 in 2020.
The hospital also increased testing of appropriate patients for CDI within the first 3 days of admission, going from 54% in 2014 to 81% in late 2019.
"By testing patients within 3 days of admission, we discovered that many had acquired C difficile before admission," Walter said. "I don't think we realized how prevalent C difficile was in the community."
"Effective collaboration within the healthcare setting is a highly effective way to implement and sustain evidence-based practices related to infection reduction. When buy-in is obtained from the top, and pertinent stakeholders are engaged for their expertise, we can see sustainable change and improved patient outcomes," Galvan, who was not involved in the study, said in an email.
Douglas S. Paauw, MD, a professor of medicine and chair for patient-centered clinical education at the University of Washington School of Medicine in Seattle, told Medscape Medical News that the team's most important interventions were changing the environmental cleaning protocol and using agents that kill C difficile spores.
"We know that as many as 10% to 20% of hospitalized patients carry C difficile. Cleaning only the rooms where you know you have C difficile (isolation rooms) will miss most of it," said Dr Paauw, who was also not involved in the study. "Cleaning every room with cleaners that actually work is very important but costs money."
Handwashing With Soap and Water Works; Alcohol Hand Gels Do Not
"We know that handwashing with soap and water is the most important way to prevent hospital C difficile transmission," Dr Paauw noted. "Handwashing protocols implemented prior to the study were probably a big part of the team's success."
Handwashing with soap and water works, but alcohol hand gels do not, he cautioned.
The authors plan to conduct further related research.
The study was not funded. All study authors, as well as Galvan and Dr Paauw, have reported no relevant financial interests.
Am J Infect Control. Published online May 11, 2022.
Implications for the Healthcare Team
The healthcare team at multiple levels should be invested in reducing the risk of HO-CDI. |